The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials
Abstract
Purpose: Patient-reported outcomes (PROs), routinely collected as a part of cancer clinical trials, have been linked with survival in numerous clinical studies, but a comprehensive critical review has not been reported. This study systematically assessed the impact of PROs on patient survival after a cancer diagnosis within the context of clinical trials. Design: Cancer clinical trials that assessed baseline PROs and mortality were identified through MEDLINE (through December 2006) supplemented by the Cochrane database, American Society of Clinical Oncology/European Society for Medical Oncology abstracts and hand searches. Inclusion criteria were publication in English language and use of multivariate analyses of PROs that controlled for one or more clinical factors. Two raters reviewed each study, abstracted data, and assessed study quality; two additional raters verified abstractions. Results: In 36 of 39 studies (N = 13,874), at least one PRO was significantly associated with survival (P < .05) in multivariate analysis, with varying effect sizes. Studies of lung (n = 12) and breast cancer (n = 8) were most prevalent. The most commonly assessed PRO was quality of life, measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 in 56% of studies. Clinical variables adjusted for included performance status (PS), treatment arm, stage, weight loss, and serum markers. Results indicated that PROs provide distinct prognostic information beyond standard clinical measures in cancer clinical trials. Conclusion: PROs might be considered for stratification purposes in future trials, as they were often better predictors of survival than PS. Studies are needed to determine whether interventions that improve PROs also increase survival and to identify explanatory mechanisms through which PROs relate to survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER
Spiegel, D., Kraemer, H., Bloom, J., & Gottheil, E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91551-1 · Cited by 2,353
Quality of life and pharmacoeconomics in clinical trials
Spilker, B. (1996) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,862
Tannock, I. F., Osoba, D., Stockler, M. R., Ernst, D. S., Neville, A. J., Moore, M. J., Armitage, G. R., Wilson, J. J., Venner, P. M., Coppin, C. M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1756 · Cited by 1,580
Sprangers, M. A. G., & Aaronson, N. K. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90052-o · Cited by 1,081
The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer
Goodwin, P. J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., Drysdale, E., Hundleby, M., Chochinov, H. M., Navarro, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011871 · Cited by 891
Mapes, D. L., Lopes, A. A., Satayathum, S., Mccullough, K. P., Goodkin, D. A., Locatelli, F., Fukuhara, S., Young, E. W., Kurokawa, K., Saito, A., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00072.x · Cited by 858
Chau, I., Norman, A. R., Cunningham, D., Waters, J. S., Oates, J., & Ross, P. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.154 · Cited by 524
Maione, P., Perrone, F., Gallo, C., Manzione, L., Piantedosi, F., Barbera, S., Cigolari, S., Rosetti, F., Piazza, E., Robbiati, S. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.527 · Cited by 478
Loprinzi, C. L., Laurie, J. A., Wieand, H. S., Krook, J. E., Novotny, P. J., Kugler, J. W., Bartel, J., Law, M., Bateman, M., & Klatt, N. E. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.601 · Cited by 384
Lessons learned from measuring health-related quality of life in oncology.
Osoba, D. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.608 · Cited by 381
Sneeuw, K. C. A., Sprangers, M. A. G., & Aaronson, N. K. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00479-1 · Cited by 374
Rummans, T. A., Clark, M. M., Sloan, J. A., Frost, M. H., Bostwick, J. M., Atherton, P. J., Johnson, M. E., Gamble, G., Richardson, J., Brown, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.209 · Cited by 353
Quality of life assessment. An independent prognostic variable for survival in lung cancer
Ganz, P. A., Jack Lee, J., & Siau, J. (1991) · Cancer · doi:10.1002/1097-0142(19910615)67:12<3131::aid-cncr2820671232>3.0.co;2-4 · Cited by 349
Coates, A., Gebski, V, Signorini, D., Murray, P., McNeil, D., Byrne, M., & Forbes, J. F. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.12.1833 · Cited by 313
Cognitive Function as a Predictor of Survival in Patients With Recurrent Malignant Glioma
Meyers, C. A., Hess, K. R., Yung, W. K. A., & Levin, V. A. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.646 · Cited by 271
Winer, E. P., Berry, D. A., Woolf, S., Duggan, D., Kornblith, A., Harris, L. N., Michaelson, R. A., Kirshner, J. A., Fleming, G. F., Perry, M. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.048 · Cited by 270
Baseline quality of life predicts survival in patients with advanced colorectal cancer
Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00098-9 · Cited by 244
Dancey, J., Zee, B., Osoba, D., Whitehead, M., Lu, F., Kaizer, L., Latreille, J., & Pater, J. L. (1997) · Quality of Life Research · doi:10.1023/a:1026442201191 · Cited by 243
Outcomes Assessment in Cancer: Measures, Methods and Applications
(2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545856 · Cited by 243
Fan, V. S., Curtis, J. R., Tu, S.-P., McDonell, M. B., & Fihn, S. D. (2002) · Chest · doi:10.1378/chest.122.2.429 · Cited by 240
Herndon, J. E., Fleishman, S., Kornblith, A. B., Kosty, M., Green, M. R., & Holland, J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990115)85:2<333::aid-cncr10>3.0.co;2-q · Cited by 193
Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas
Brown, P. D., Ballman, K. V., Rummans, T. A., Maurer, M. J., Sloan, J. A., Boeve, B. F., Gupta, L., Tang-Wai, D. F., Arusell, R. M., Clark, M. M., et al. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-7020-9 · Cited by 192
Efficace, F., Bottomley, A., Smit, E. F., Lianes, P., Legrand, C., Debruyne, C., Schramel, F., Smit, H. J., Gaafar, R., Biesma, B., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl183 · Cited by 184
Self-citationQuality-of-Life Scores Predict Outcome in Metastatic but Not Early Breast Cancer
Coates, A. S., Hürny, C., Peterson, H. F., Bernhard, J., Castiglione-Gertsch, M., Gelber, R. D., Goldhirsch, A., & for the International Breast Cancer Study Group (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3768 · Cited by 181
Kramer, J. A., Curran, D., Piccart, M., de Haes, J. C. J. M., Bruning, P., Klijn, J., Van Hoorebeeck, I., & Paridaens, R. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00144-1 · Cited by 166
Quality-of-Life Assessment in Oncology
Sprangers, M. A. G. (2002) · Acta Oncologica · doi:10.1080/02841860260088764 · Cited by 166
Efficace, F., Biganzoli, L., Piccart, M., Coens, C., Van Steen, K., Cufer, T., Coleman, R. E., Calvert, H. A., Gamucci, T., Twelves, C., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.014 · Cited by 162
Self-citationPrognostic factors for patients with inoperable non-small cell lung cancer, limited disease
Kaasa, S., Mastekaasa, A., & Lund, E. (1989) · Radiotherapy and Oncology · doi:10.1016/0167-8140(89)90091-1 · Cited by 156
Courneya, K. S., SEGAL, R. J., Reid, R. D., Jones, L. W., Malone, S. C., Venner, P. M., Parliament, M. B., Scott, C. G., Quinney, H. A., & Wells, G. A. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.11.010 · Cited by 146
Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review
Hauser, C. A., Stockler, M. R., & Tattersall, M. H. N. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0079-9 · Cited by 144
Efficace, F., Bottomley, A., Coens, C., Steen, K. V., Conroy, T., Schöffski, P., Schmoll, H., Cutsem, E. V., & Köhne, C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.025 · Cited by 143
Self-citationDorr, D. A., Jones, S. S., Burns, L., Donnelly, S. M., Brunker, C. P., Wilcox, A. B., & Clayton, P. D. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00681.x · Cited by 142
Coates, A. S., Thomson, D. B., McLeod, G., Hersey, P., Gill, P. G., Olver, I. N., Kefford, R. F., Lowenthal, R. M., Beadle, G., & Walpole, E. T. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90115-v · Cited by 136
Psycho-oncology and cancer: psychoneuroimmunology and cancer
Kiecolt-Glaser, J. K., Robles, T., Heffner, K. L., Loving, T. J., & Glaser, R. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf655 · Cited by 135
Monk, B. J., Huang, H. Q., Cella, D. F., & Long, H. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.522 · Cited by 131
Eton, D. T., Fairclough, D. L., Cella, D. F., Yount, S., Bonomi, P., & Johnson, D. H. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.128 · Cited by 128
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma
Yeo, W., Mo, F. K. F., Koh, J., Chan, A. T. �., Leung, T., Hui, P., Chan, S. L., Tang, A., Lee, J. J., Mok, T. S. K., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl065 · Cited by 127
Roychowdhury, D., Hayden, A., & Liepa, A. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.166 · Cited by 121
Efficace, F., Therasse, P., Piccart, M. J., Coens, C., Steen, K. V., Wełnicka-Jaśkiewicz, M., Čufer, T., Dyczka, J., Lichinitser, M. R., Shepherd, L. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.060 · Cited by 117
Self-citationNowak, A. K., Stockler, M. R., & Byrne, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.147 · Cited by 111
Wislöff, F., & Hjorth, M. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.222667.x · Cited by 108
Dubois, D. J., Dhawan, R., de Velde, H. J. V., Esseltine, D. L., Gupta, S. K., Viala, M., & de la Loge, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0824 · Cited by 102
Seidman, A. D., Portenoy, R. K., Yao, T. J., Lepore, J. M., Mont, E. K., Kortmansky, J. S., Onetto-Pothier, N., Ren, L., Grechko, J., Beltangady, M. S., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.17.1316 · Cited by 97
Psychological Symptoms and Disease-Free and Overall Survival in Women With Stage II Breast Cancer
Tross, S., Herndon, J., Korzun, A. E., Kornblith, A. B., Cella, D. F., Holland, J. F., Raich, P. C., Johnson, A., Kiang, D. T., Perloff, M., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.10.661 · Cited by 92
Singh, J. A., Nelson, D. B., Fink, H. A., & Nichol, K. L. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2004.08.001 · Cited by 85
Cunningham, W. E., Crystal, S., Bozzette, S. A., & Hays, R. D. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.30402.x · Cited by 84
Brown, J. M., Thorpe, H. C., Napp, V., Fairlamb, D. J., Gower, N. H., Milroy, R., Parmar, M., Rudd, R., Spiro, S. G., Stephens, R. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.158 · Cited by 84
Collette, L., van Andel, G., Bottomley, A., Oosterhof, G. O. N., Albrecht, W., de Reijke, T. M., & Fosså, S. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.089 · Cited by 78
Self-citationLipscomb, J. (2004) · Cited by 74
Sullivan, P. W., Nelson, J. B., Mulani, P. M., & Sleep, D. J. (2006) · Quality of Life Research · doi:10.1007/s11136-006-0003-2 · Cited by 70
Quality of Life in Lung Cancer Surgical Adjuvant Trials
Ruckdeschel, J. C., & Piantadosi, S. (1994) · CHEST Journal · doi:10.1378/chest.106.6_supplement.324s · Cited by 61
Jerkeman, M., Kaasa, S., Hjermstad, M. J., Kvaløy, S., & Cavallin-Ståhl, E. K. (2001) · Medical Oncology · doi:10.1385/mo:18:1:85 · Cited by 54
Fan, V. S., Au, D. H., McDonell, M. B., & Fihn, S. D. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.08.004 · Cited by 52
Moinpour, C. M., Lyons, B., Grevstad, P. K., Lovato, L., Crowley, J. J., Czaplicki, K., Buckner, Z. M., Ganz, P. A., Kelly, K. L., & Gandara, D. R. (2002) · Quality of Life Research · doi:10.1023/a:1015048908822 · Cited by 50
Naughton, M. J., Herndon, J. E., Shumaker, S. A., Miller, A. A., Kornblith, A. B., Chao, D., & Holland, J. C. (2002) · Quality of Life Research · doi:10.1023/a:1015257121369 · Cited by 47
Kemeny, M. E. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00069-7 · Cited by 43
Quality of life in breast cancer: what have we learned and where do we go from here?
Ganz, P. A., & Goodwin, P. J. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545856.005 · Cited by 28
The clinical value and meaning of health-related quality-of-life outcomes in oncology
Osoba, D. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545856.019 · Cited by 22
Measuring the Effect of Cancer on Health-Related Quality of Life
Osoba, D. (1995) · PharmacoEconomics · doi:10.2165/00019053-199507040-00005 · Cited by 17
Increasing Trial Generalizability
Gotay, C. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5120 · Cited by 15
Self-citation
Cited by
Depression as a predictor of disease progression and mortality in cancer patients: A Meta‐Analysis
Satin, J. R., Linden, W., & Phillips, M. J. (2009) · Cancer · doi:10.1002/cncr.24561 · Cited by 972
“In a recent review of the prognostic significance of patientreported outcomes in cancer clinical trials, quality of life was shown to commonly predict survival perhaps even better than performance status.(85) Because the latter review was not a meta-analysis and used different inclusion criteria, we cannot compare the…”
ResultExercise interventions on health-related quality of life for cancer survivors
Mishra, S. I., Scherer, R. W., Geigle, P. M., Berlanstein, D. R., Topaloglu, O., Gotay, C. C., & Snyder, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007566.pub2 · Cited by 808
Self-citationEarly palliative care for adults with advanced cancer
Haun, M. W., Estel, S., Rücker, G., Friederich, H.-C., Villalobos, M., Thomas, M., & Hartmann, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011129.pub2 · Cited by 757
Mishra, S. I., Scherer, R. W., Snyder, C., Geigle, P. M., Berlanstein, D. R., & Topaloglu, O. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008465.pub2 · Cited by 679
Quinten, C., Coens, C., Mauer, M., Comte, S., Sprangers, M. A., Cleeland, C., Osoba, D., Bjordal, K., & Bottomley, A. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70200-1 · Cited by 659
Self-citation
Metadata
- Authors
- Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-03-10
- Volume
- 26
- Issue
- 8
- Pages
- 1355-1363
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2002330540
- Cited by
- 644
- References
- 60
- FWCI
- 15.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.